Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease.

Area of Science:

• Cardiovascular Research
• Cellular Biology
• Mitochondrial Medicine

Background:

• Cardiovascular diseases (CVDs) are the leading global cause of mortality, significantly impacting quality of life.
• Age-related CVDs like atherosclerosis, myocardial infarction (MI), and heart failure (HF) pose a growing health and economic burden due to increasing life expectancy.
• Understanding the fundamental mechanisms of CVD is crucial for developing effective treatments.

Purpose of the Study:

• To review the roles of cellular senescence and mitochondrial dysfunction in the development of cardiovascular diseases.
• To assess recent advancements in targeting mitochondrial dysfunction and cellular senescence for CVD treatment.
• To identify therapeutic strategies that address both cellular senescence and mitochondrial dysfunction for maximum clinical potential.

Main Methods:

• Literature review focusing on cellular senescence and mitochondrial dysfunction in CVD.
• Analysis of recent research on targeting mitochondrial dysfunction (energy metabolism, oxidative stress, dynamics, apoptosis, mitophagy).
• Evaluation of therapeutic strategies influencing both cellular senescence and mitochondrial pathways.

Main Results:

• Cellular senescence and mitochondrial dysfunction are established contributors to cardiovascular disease.
• Recent advances include targeting energy starvation, oxidative stress, mitochondrial dynamics, apoptosis, and mitophagy.
• Therapies that simultaneously target senescence and mitochondrial dysfunction show significant clinical promise.

Conclusions:

• Cellular senescence and mitochondrial dysfunction are critical factors in cardiovascular disease pathogenesis.
• Targeting these pathways, particularly through combined strategies, offers promising avenues for novel CVD therapies.
• Further research into these interconnected mechanisms can lead to more effective clinical interventions for cardiovascular conditions.